A role for mammalian target of rapamycin in regulating T cell activation versus anergy

Yan Zheng, Samuel L. Coffins, Michael A. Lutz, Amy N. Allen, Thomas P. Kole, Paul E. Zarek, Jonathan Powell

Research output: Contribution to journalArticle

Abstract

Whether TCR engagement leads to activation or tolerance is determined by the concomitant delivery of multiple accessory signals, cytokines, and environmental cues. In this study, we demonstrate that the mammalian target of rapamycin (mTOR) integrates these signals and determines the outcome of TCR engagement with regard to activation or energy. In vitro, Ag recognition in the setting of mTOR activation leads to full immune responses, whereas recognition in the setting of mTOR inhibition results in anergy. Full T cell activation is associated with an increase in the phosphorylation of the downstream mTOR target S6 kinase 1 at Thr421/Ser424 and an increase in the mTOR-dependent cell surface expression of transferrin receptor (CD71). Alternatively, the induction of anergy results in markedly less S6 kinase 1 Thr421/Ser424 phospliorylation and CD71 surface expression. Likewise, the reversal of anergy is associated not with proliferation, but rather the specific activation of mTOR. Importantly, T cells engineered to express a rapamycin-resistant mTOR construct are resistant to anergy induction caused by rapamycin. In vivo, mTOR inhibition promotes T cell anergy under conditions that would normally induce priming. Furthermore, by examining CD71 surface expression, we are able to distinguish and differentially isolate anergic and activated T cells in vivo. Overall, our data suggest that by integrating environmental cues, mTOR plays a central role in determining the outcome of Ag recognition.

Original languageEnglish (US)
Pages (from-to)2163-2170
Number of pages8
JournalJournal of Immunology
Volume178
Issue number4
StatePublished - Feb 15 2007

Fingerprint

Sirolimus
T-Lymphocytes
Ribosomal Protein S6 Kinases
Cues
Transferrin Receptors
Phosphorylation
Cytokines

ASJC Scopus subject areas

  • Immunology

Cite this

Zheng, Y., Coffins, S. L., Lutz, M. A., Allen, A. N., Kole, T. P., Zarek, P. E., & Powell, J. (2007). A role for mammalian target of rapamycin in regulating T cell activation versus anergy. Journal of Immunology, 178(4), 2163-2170.

A role for mammalian target of rapamycin in regulating T cell activation versus anergy. / Zheng, Yan; Coffins, Samuel L.; Lutz, Michael A.; Allen, Amy N.; Kole, Thomas P.; Zarek, Paul E.; Powell, Jonathan.

In: Journal of Immunology, Vol. 178, No. 4, 15.02.2007, p. 2163-2170.

Research output: Contribution to journalArticle

Zheng, Y, Coffins, SL, Lutz, MA, Allen, AN, Kole, TP, Zarek, PE & Powell, J 2007, 'A role for mammalian target of rapamycin in regulating T cell activation versus anergy', Journal of Immunology, vol. 178, no. 4, pp. 2163-2170.
Zheng Y, Coffins SL, Lutz MA, Allen AN, Kole TP, Zarek PE et al. A role for mammalian target of rapamycin in regulating T cell activation versus anergy. Journal of Immunology. 2007 Feb 15;178(4):2163-2170.
Zheng, Yan ; Coffins, Samuel L. ; Lutz, Michael A. ; Allen, Amy N. ; Kole, Thomas P. ; Zarek, Paul E. ; Powell, Jonathan. / A role for mammalian target of rapamycin in regulating T cell activation versus anergy. In: Journal of Immunology. 2007 ; Vol. 178, No. 4. pp. 2163-2170.
@article{0f705b816e804eeca6ee56c2f21cd533,
title = "A role for mammalian target of rapamycin in regulating T cell activation versus anergy",
abstract = "Whether TCR engagement leads to activation or tolerance is determined by the concomitant delivery of multiple accessory signals, cytokines, and environmental cues. In this study, we demonstrate that the mammalian target of rapamycin (mTOR) integrates these signals and determines the outcome of TCR engagement with regard to activation or energy. In vitro, Ag recognition in the setting of mTOR activation leads to full immune responses, whereas recognition in the setting of mTOR inhibition results in anergy. Full T cell activation is associated with an increase in the phosphorylation of the downstream mTOR target S6 kinase 1 at Thr421/Ser424 and an increase in the mTOR-dependent cell surface expression of transferrin receptor (CD71). Alternatively, the induction of anergy results in markedly less S6 kinase 1 Thr421/Ser424 phospliorylation and CD71 surface expression. Likewise, the reversal of anergy is associated not with proliferation, but rather the specific activation of mTOR. Importantly, T cells engineered to express a rapamycin-resistant mTOR construct are resistant to anergy induction caused by rapamycin. In vivo, mTOR inhibition promotes T cell anergy under conditions that would normally induce priming. Furthermore, by examining CD71 surface expression, we are able to distinguish and differentially isolate anergic and activated T cells in vivo. Overall, our data suggest that by integrating environmental cues, mTOR plays a central role in determining the outcome of Ag recognition.",
author = "Yan Zheng and Coffins, {Samuel L.} and Lutz, {Michael A.} and Allen, {Amy N.} and Kole, {Thomas P.} and Zarek, {Paul E.} and Jonathan Powell",
year = "2007",
month = "2",
day = "15",
language = "English (US)",
volume = "178",
pages = "2163--2170",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "4",

}

TY - JOUR

T1 - A role for mammalian target of rapamycin in regulating T cell activation versus anergy

AU - Zheng, Yan

AU - Coffins, Samuel L.

AU - Lutz, Michael A.

AU - Allen, Amy N.

AU - Kole, Thomas P.

AU - Zarek, Paul E.

AU - Powell, Jonathan

PY - 2007/2/15

Y1 - 2007/2/15

N2 - Whether TCR engagement leads to activation or tolerance is determined by the concomitant delivery of multiple accessory signals, cytokines, and environmental cues. In this study, we demonstrate that the mammalian target of rapamycin (mTOR) integrates these signals and determines the outcome of TCR engagement with regard to activation or energy. In vitro, Ag recognition in the setting of mTOR activation leads to full immune responses, whereas recognition in the setting of mTOR inhibition results in anergy. Full T cell activation is associated with an increase in the phosphorylation of the downstream mTOR target S6 kinase 1 at Thr421/Ser424 and an increase in the mTOR-dependent cell surface expression of transferrin receptor (CD71). Alternatively, the induction of anergy results in markedly less S6 kinase 1 Thr421/Ser424 phospliorylation and CD71 surface expression. Likewise, the reversal of anergy is associated not with proliferation, but rather the specific activation of mTOR. Importantly, T cells engineered to express a rapamycin-resistant mTOR construct are resistant to anergy induction caused by rapamycin. In vivo, mTOR inhibition promotes T cell anergy under conditions that would normally induce priming. Furthermore, by examining CD71 surface expression, we are able to distinguish and differentially isolate anergic and activated T cells in vivo. Overall, our data suggest that by integrating environmental cues, mTOR plays a central role in determining the outcome of Ag recognition.

AB - Whether TCR engagement leads to activation or tolerance is determined by the concomitant delivery of multiple accessory signals, cytokines, and environmental cues. In this study, we demonstrate that the mammalian target of rapamycin (mTOR) integrates these signals and determines the outcome of TCR engagement with regard to activation or energy. In vitro, Ag recognition in the setting of mTOR activation leads to full immune responses, whereas recognition in the setting of mTOR inhibition results in anergy. Full T cell activation is associated with an increase in the phosphorylation of the downstream mTOR target S6 kinase 1 at Thr421/Ser424 and an increase in the mTOR-dependent cell surface expression of transferrin receptor (CD71). Alternatively, the induction of anergy results in markedly less S6 kinase 1 Thr421/Ser424 phospliorylation and CD71 surface expression. Likewise, the reversal of anergy is associated not with proliferation, but rather the specific activation of mTOR. Importantly, T cells engineered to express a rapamycin-resistant mTOR construct are resistant to anergy induction caused by rapamycin. In vivo, mTOR inhibition promotes T cell anergy under conditions that would normally induce priming. Furthermore, by examining CD71 surface expression, we are able to distinguish and differentially isolate anergic and activated T cells in vivo. Overall, our data suggest that by integrating environmental cues, mTOR plays a central role in determining the outcome of Ag recognition.

UR - http://www.scopus.com/inward/record.url?scp=33846909503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846909503&partnerID=8YFLogxK

M3 - Article

VL - 178

SP - 2163

EP - 2170

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 4

ER -